Panel Discussion: Integrating Natural History & Real- World Evidence to Strengthen Small-Population Trials & Reduce Dependence on Conventional Controls
2:00 pm - Wednesday 17th March 2027
- Defining when external or historical controls can provide regulatory-grade evidence
- Improving data quality, standardisation and comparability across real-world datasets
- Aligning industry and regulators on appropriate applications in rare and segmented CKD populations
Speakers:
Senior Vice President - Clinical Development & Drug Safety ,Pharmacovigilance
Travere Therapeutics, Inc.